Table 1.
The Relationship Between The Preoperative AAPR And Clinicopathological Variables
| Variables | Total (n=230) | AAPR <0.68 | AAPR ≥0.68 | P-value |
|---|---|---|---|---|
| Age | ||||
| ≤55 years | 115 (50%) | 52 (45.2%) | 63 (54.8%) | <0.001* |
| >55 years | 115 (50%) | 89 (77.4%) | 26 (22.6%) | |
| menopause | ||||
| No | 98 (42.6%) | 41 (41.8%) | 57 (58.2%) | <0.001* |
| Yes | 132 (57.4%) | 100 (75.8%) | 32 (24.2%) | |
| FIGO stage | ||||
| IB | 201 (87.4%) | 120 (59.7%) | 81 (40.3%) | 0.189 |
| IIA | 29 (12.6%) | 21 (72.4%) | 8 (27.6%) | |
| Pathological type | ||||
| SCC | 192 (83.5%) | 123 (64.1%) | 69 (35.9%) | 0.054 |
| No-SCC | 38 (16.5%) | 18 (47.4%) | 20 (52.6%) | |
| Tumor Size | ||||
| ≤2cm | 113 (49.1%) | 73 (64.6%) | 40 (35.4%) | 0.313 |
| >2cm | 117 (50.9%) | 68 (58.1%) | 49 (41.9%) | |
| Histologic grade | ||||
| I-II | 124 (53.9%) | 81 (65.3%) | 43 (34.7%) | 0.176 |
| III | 106 (46.1%) | 60 (56.6%) | 46 (43.4%) | |
| Depth of invasion | ||||
| <2/3 | 172 (74.8%) | 99 (57.6%) | 73 (42.4%) | 0.045* |
| ≥2/3 | 58 (25.2%) | 42 (72.4%) | 16 (27.6%) | |
| LVSI | ||||
| No | 200 (87.0%) | 123 (61.5%) | 77 (38.5%) | 0.875 |
| Yes | 30 (13.0%) | 18 (60%) | 12 (40%) | |
| LNM | ||||
| No | 196 (85.2%) | 121 (61.7%) | 75 (38.3%) | 0.748 |
| Yes | 34 (14.8%) | 20 (58.8%) | 14 (41.2%) | |
| Vaginal invasion | ||||
| No | 218 (94.8%) | 133 (61.0%) | 85 (39.0%) | 0.770 |
| Yes | 12 (5.2%) | 8 (66.7%) | 4 (33.3%) | |
| Adjuvant therapy | ||||
| No | 84 (36.5%) | 56 (66.7%) | 28 (33.3%) | 0.419 |
| Chemoradiotherapy | 57 (24.8%) | 31 (54.4%) | 26 (45.6%) | |
| Chemotherapy | 84 (36.5%) | 50 (59.5%) | 34 (40.5%) | |
| Radiotherapy | 5 (2.2%) | 4 (80%) | 1 (20%) | |
| ALB(g/L) | 46.3±4.2 | 46.0±4.4 | 46.8±4.0 | 0.141 |
| ALP(U/L) | 81.3±57.0 | 97.8±67.3 | 55.1±10.5 | <0.001* |
Notes: Independent-Samples T test or Mann–Whitney U-test was employed for continuous variables. Chi-squared test or Fisher’s exact test was employed for categorical variables. *P<0.05.
Abbreviations: AAPR, albumin/alkaline phosphatase ratio; FIGO, International Federation of Gynecology and Obstetrics; SCC, squamous cell carcinoma; LVSI, lympho-vascular space invasion; LNM, lymph node metastasis; ALB, albumin; ALP, alkaline phosphatase.